# ORENCIA

NDC: 0003-2187
Generic name: abatacept
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20090101

FDA application: BLA125118

## Active ingredients

- ABATACEPT: 250 mg/15mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-2187"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-2187
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0836c6ac-ee37-5640-2fed-a3185a0b16eb